| Krystexxa |
125293 |
002 |
351(a) |
pegloticase |
Injection |
Intravenous |
8MG/50ML (0.16MG/ML) |
Single-Dose Vial |
2025/08/29
|
Horizon Therapeutics Ireland DAC |
Rx |
Licensed |
N/A |
N/A |
| Leqembi IQLIK |
761375 |
001 |
351(a) |
lecanemab-irmb |
Injection |
Subcutaneous |
360MG/1.8ML (200MG/ML) |
Autoinjector |
2025/08/29
|
Eisai, Incorporated |
Rx |
Licensed |
N/A |
N/A |
| Bildyos |
761444 |
001 |
351(k) Interchangeable |
denosumab-nxxp |
Injection |
Subcutaneous |
60MG/ML |
Single-Dose Vial |
2025/08/29
|
Shanghai Henlius Biotech, Inc. |
Rx |
Licensed |
denosumab |
Prolia |
| Bildyos |
761444 |
002 |
351(k) Interchangeable |
denosumab-nxxp |
Injection |
Subcutaneous |
60MG/ML |
Pre-Filled Syringe |
2025/08/29
|
Shanghai Henlius Biotech, Inc. |
Rx |
Licensed |
denosumab |
Prolia |
| Bilprevda |
761444 |
003 |
351(k) Interchangeable |
denosumab-nxxp |
Injection |
Subcutaneous |
120MG/1.7ML (70MG/ML) |
Single-Dose Vial |
2025/08/29
|
Shanghai Henlius Biotech, Inc. |
Rx |
Licensed |
denosumab |
Xgeva |
| Comirnaty |
125742 |
004 |
351(a) |
COVID-19 Vaccine, mRNA |
For Injection |
Intramuscular |
10UG |
Single-Dose Vial |
2025/08/27
|
BioNTech Manufacturing GmbH |
Rx |
Licensed |
N/A |
N/A |
| PAPZIMEOS |
125832 |
001 |
351(a) |
zopapogene imadenovec-drba |
For Injection |
Subcutaneous |
5x10^11PARTICLE UNITS |
Single-Dose Vial |
2025/08/14
|
Precigen, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Skytrofa |
761177 |
010 |
351(a) |
lonapegsomatropin-tcgd |
For Injection |
Subcutaneous |
0.7MG |
Single-Dose Cartridge |
2025/07/25
|
Ascendis Pharma Endocrinology Division A/S |
Rx |
Licensed |
N/A |
N/A |
| Skytrofa |
761177 |
011 |
351(a) |
lonapegsomatropin-tcgd |
For Injection |
Subcutaneous |
1.4MG |
Single-Dose Cartridge |
2025/07/25
|
Ascendis Pharma Endocrinology Division A/S |
Rx |
Licensed |
N/A |
N/A |
| Skytrofa |
761177 |
012 |
351(a) |
lonapegsomatropin-tcgd |
For Injection |
Subcutaneous |
1.8MG |
Single-Dose Cartridge |
2025/07/25
|
Ascendis Pharma Endocrinology Division A/S |
Rx |
Licensed |
N/A |
N/A |
| Skytrofa |
761177 |
013 |
351(a) |
lonapegsomatropin-tcgd |
For Injection |
Subcutaneous |
2.1MG |
Single-Dose Cartridge |
2025/07/25
|
Ascendis Pharma Endocrinology Division A/S |
Rx |
Licensed |
N/A |
N/A |
| Skytrofa |
761177 |
014 |
351(a) |
lonapegsomatropin-tcgd |
For Injection |
Subcutaneous |
2.5MG |
Single-Dose Cartridge |
2025/07/25
|
Ascendis Pharma Endocrinology Division A/S |
Rx |
Licensed |
N/A |
N/A |
| Shingrix |
125614 |
003 |
351(a) |
Zoster Vaccine Recombinant, Adjuvanted |
Injection |
Intramuscular |
50UG |
Pre-Filled Syringe |
2025/07/16
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
N/A |
|
| Kirsty |
761188 |
001 |
351(k) Interchangeable |
insulin aspart-xjhz |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2025/07/15
|
Biocon Biologics Inc. |
Rx |
Licensed |
insulin aspart |
Novolog |
| Kirsty |
761188 |
002 |
351(k) Interchangeable |
insulin aspart-xjhz |
Injection |
Intravenous, Subcutaneous |
1,000UNITS/10ML (100UNITS/ML) |
Multi-Dose Vial |
2025/07/15
|
Biocon Biologics Inc. |
Rx |
Licensed |
insulin aspart |
Novolog |
| Spikevax |
125752 |
005 |
351(a) |
COVID-19 Vaccine, mRNA |
Injection |
Intramuscular |
25UG/0.25mL |
Pre-Filled Syringe |
2025/07/09
|
ModernaTX, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lynozyfic |
761400 |
001 |
351(a) |
linvoseltamab-gcpt |
Injection |
Intravenous |
5MG/2.5ML (2MG/ML) |
Single-Dose Vial |
2025/07/02
|
Regeneron Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lynozyfic |
761400 |
002 |
351(a) |
linvoseltamab-gcpt |
Injection |
Intravenous |
200MG/10ML (20MG/ML) |
Single-Dose Vial |
2025/07/02
|
Regeneron Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Pyzchiva |
761373 |
004 |
351(k) Interchangeable |
ustekinumab-ttwe |
Injection |
Subcutaneous |
45MG/0.5ML |
Autoinjector |
2025/06/27
|
Samsung Bioepis Co., Ltd. |
Rx |
Licensed |
ustekinumab |
Stelara |
| Pyzchiva |
761373 |
005 |
351(k) Interchangeable |
ustekinumab-ttwe |
Injection |
Subcutaneous |
90MG/ML |
Autoinjector |
2025/06/27
|
Samsung Bioepis Co., Ltd. |
Rx |
Licensed |
ustekinumab |
Stelara |